National statistics

MRSA, MSSA and Gram-negative bacteraemia and CDI: annual report

Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.

From:
UK Health Security Agency
Published
10 July 2014
Last updated
16 February 2024 — See all updates

Applies to England

Documents

Annual epidemiological commentary: Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2022 to 2023

Ref: GOV-16212

Accompanying data for Gram-negative, MRSA and MSSA bacteraemia and C. difficile infection data, up to and including financial year 2022 to 2023

Ref: GOV-16212

ODS, 257 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

MRSA, MSSA and Gram-negative bacteraemia and CDI: infographics for England, financial year 2022 to 2023

Ref: GOV-15486

Details

These official statistics were independently reviewed by the Office for Statistics Regulation in May 2022. They comply with the standards of trustworthiness, quality and value in the Code of Practice for Statistics and should be labelled ‘accredited official statistics’. Accredited official statistics are called National Statistics in the Statistics and Registration Service Act 2007. Further explanation of accredited official statistics can be found on the Office for Statistics Regulation website.

View the pre-release access list covering all mandatory HCAI statistical releases.

The following financial year data is included in the latest annual epidemiological commentary for meticillin resistant Staphylococcus aureus (MRSA), meticillin susceptible Staphylococcus aureus (MSSA), Escherichia coli (E. coli), Klebsiella species (Klebsiella spp.) and Pseudomonas aeruginosa (P. aeruginosa) bacteraemia and Clostridioides difficile infection (CDI).

From September 2022:

  • MRSA bacteraemia: April 2007 to March 2022
  • MSSA bacteraemia: April 2011 to March 2022
  • E. coli bacteraemia: April 2012 to March 2022
  • Klebsiella spp. bacteraemia: April 2017 to March 2022
  • P. aeruginosa bacteraemia: April 2017 to March 2022
  • C. difficile infection: April 2007 to March 2022

Annual trust and sub-integrated care board tables

For annual publications for previous financial years please see:

Enquiries or feedback

To request copies of the report in PDF format, please contact publications@ukhsa.gov.uk

For any other enquiries or feedback, contact mandatory.surveillance@ukhsa.gov.uk

Published 10 July 2014
Last updated 16 February 2024 + show all updates

  1. Corrected errors, as detailed in the 'Corrections to these statistics' section of the main 2022 to 2023 report.

  2. Added annual epidemiological commentary up to and including the financial year April 2022 to March 2023. Archived April 2021 to March 2022 data.

  3. Added annual epidemiological commentary up to and including the financial year April 2021 to March 2022. Archived April 2020 to March 2021 data.

  4. Added annual epidemiological commentary up to and including the financial year April 2020 to March 2021. Archived April 2019 to March 2020 data.

  5. Added annual epidemiological commentary up to and including the financial year April 2019 to March 2020, archived April 2018 to March 2019 data.

  6. Added amended commentary with corrected values for age and sex rates and population in tables 28 and 29 on page 60.

  7. Added annual epidemiological commentary up to and including the financial year April 2018 to March 2019, archived April 2017 to March 2018 data.

  8. Archived all historic annual reports, added headline information link and updated the headline information for all data collections, for financial year 2017 to 2018, to correct data for hospital/community-onset comparisons.

  9. Added annual epidemiological commentary up to and including the financial year April 2017 to March 2018.

  10. Added annual epidemiological commentary up to and including the financial year April 2016 to March 2017.

  11. Added annual epidemiological commentary up to and including the financial year April 2015 to March 2016.

  12. Annual epidemiological commentary up to and including the financial year April 2014 to March 2015 added.

  13. First published.

Related content